Inventor

Robert H. Zimmer

Inventor

Mulhouse, FR

Overview

2000–2021

Patent span

Human necessities

Primary field (CPC A)

Patents· 13 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary

A61KPreparations for medical, dental or toiletry purposes32%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%

C07KPeptides24%

C07DHeterocyclic compounds6%

C08GMacromolecular compounds obtained otherwise than by reactions only involving unsaturated carbon-to-carbon bonds3%

C08LCompositions of macromolecular compounds3%

Y02ATechnologies for adaptation to climate change3%

PatentTitleYear

10,889,627Pro-drug peptide with improved pharmaceutical properties2021 10,398,750Peptide-oligourea chimeric compounds and methods of their use2019 10,213,482Methods of treating chronic inflammatory diseases2019 9,657,072'Modified peptides and their use for treating autoimmune diseases'2017 9,487,559'Compositions comprising multivalent synthetic ligands of surface nucleolin and glycosaminoglycans'2016 9,243,030'Optically pure compounds for improved therapeutic efficiency'2016 8,138,145'Hybrid oligomers, their preparation process and pharmaceutical compositions containing them'2012 8,080,519'Compositions and methods for enhanced pharmacological activity of compositions comprising peptide drug substances'2011 7,691,807'Hybrid oligomers, their preparation process and pharmaceutical compositions containing them'2010 7,671,029'Compositions and methods for enhanced pharmacological activity of compositions comprising peptide drug substances'2010 6,908,900'COMPOSITIONS AND METHODS FOR ENHANCED PHARMACOLOGICAL ACTIVITY THROUGH ORAL AND PARENTERAL ADMINISTRATION OF COMPOSITIONS COMPRISING POLYPEPTIDE DRUG SUBSTANCES AND OTHER POORLY ABSORBED ACTIVE INGREDIENTS'2005 6,221,395'Controlled release pharmaceutical tablets containing an active principle of low water solubility'2001 6,027,748'Pharmaceutical tablet, completely coated, for controlled release of active principles that present problems of bio-availability linked to gastro-intestinal absorption'2000

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2000–2021Based in Mulhouse, FR· patent location history

2010–2019Patents assigned to CENTRE NAT RECH SCIENT (5)· patent assignee history

2010–2019Patents assigned to IMMUPHARMA FRANCE SA (4)· patent assignee history

2011–2016Patents assigned to ZIMMER ROBERT H (3)· patent assignee history

2012–2016Patents assigned to GUICHARD GILLES (2)· patent assignee history

2016Patents assigned to ELRO PHARMA SARL (2)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
CENTRE NAT RECH SCIENT	5	2010–2019
IMMUPHARMA FRANCE SA	4	2010–2019
ZIMMER ROBERT Hself	3	2011–2016
ELRO PHARMA SARL	2	2016
GUICHARD GILLES	2	2012–2016

Locations

Location	Patents	Span
Mulhouse, FR	13	2000–2021